Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Indivior Pharmaceuticals (INDV) Gains from Investment Securities (2022 - 2025)

Indivior Pharmaceuticals has reported Gains from Investment Securities over the past 4 years, most recently at -$3.0 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 250.0% year-over-year to -$3.0 million; the TTM value through Mar 2026 reached $1.0 million, down 95.45%, while the annual FY2024 figure was $22.0 million, 0.0% changed from the prior year.
  • Gains from Investment Securities for Q4 2025 was -$3.0 million at Indivior Pharmaceuticals, down from $4.0 million in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $62.0 million in Q4 2023 and troughed at -$21.0 million in Q1 2023.
  • A 4-year average of $5.0 million and a median of -$1.0 million in 2024 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: soared 463.64% in 2023 and later crashed 250.0% in 2025.
  • Year by year, Gains from Investment Securities stood at $11.0 million in 2022, then soared by 463.64% to $62.0 million in 2023, then crashed by 96.77% to $2.0 million in 2024, then crashed by 250.0% to -$3.0 million in 2025.
  • Business Quant data shows Gains from Investment Securities for INDV at -$3.0 million in Q4 2025, $4.0 million in Q2 2025, and -$1.0 million in Q1 2025.